NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application April 6, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by biospace. Read more Source: https://www.biospace.com/press-releases/nrx-pharmaceuticals-nasdaq-nrxp-announces-fda-labeling-alignment-for-nrxs-preservative-free-ketamine-application
